Serum samples from patients with TB reacted more strongly with MP

Serum samples from patients with TB reacted more strongly with MPB64 antigen than did those from uninfected individuals. In addition, serum samples from TB patients

with active infection reacted more strongly with the antigen than did samples from patients with inactive TB. When urine samples were assessed using this assay, similar results were obtained. Correlations between the data obtained from serum and urine samples were analyzed for all subjects, including uninfected individuals, and a strong positive correlation between the results of serum and urine tests (n = 36, r = 0.672) was found. The sensitivity and specificity of this assay for serum samples was 85.7 % and 85.0 %, and for urine samples 75.0 % and 85.0 %, respectively. These results suggest that dot-blot assay with MPB64 Ruxolitinib in vitro antigen could be a useful screening test for active

TB. Because urine samples can be obtained more easily than serum samples and because urine is less contagious, urine testing should probably be employed for screening purposes. Dabrafenib supplier According to the World Health Organization, about two billion people, approximately one third of the world’s population, are infected with M. tuberculosis. In 2011, around 8.8 million new cases of TB and 1.1 million deaths from this disease were reported (1). This is the greatest number of deaths caused by any single pathogen. From sub-Saharan Africa to Asia, the annual incidence of TB now exceeds 300 per 100,000. In Japan, the number of new cases of TB and its incidence has been increasing since 1997. In 2007, the number of new TB patients reached 25,311, with the total incidence rising to 19.8, which is higher than in many other developed countries (1). In Japan, a high percentage of infected elderly patients develop active TB and, in urban areas, the percentage of immigrants from Southeast

Asian countries with TB is not negligible. The diagnosis of pulmonary TB is based on the presence of respiratory symptoms (cough, sputum, and hemoptysis) and systemic symptoms (fever, malaise, and weight loss), and the findings on chest X-ray films and computed tomography scans. Examination of the patient’s sputum and gastric Glycogen branching enzyme juice, as well as auxiliary diagnostic tests such as the QuantiFERON test, tuberculin skin test, and bronchoscopy, can also be performed (2). For many years, the tuberculin skin test was the standard test for TB infection. However, this test does not become positive until 4–6 weeks after establishment of infection and prior BCG vaccination can influence its results. Accordingly, the QuantiFERON-TB Gold In-Tube, which is based on three tuberculosis-specific antigens (ESAT-6, CFP-10 and TB7.7 proteins), is now recommended as a more specific test for TB (3, 4). There have been many attempts to develop serodiagnostic tests for TB that detect antibodies targeting various structural components of M. tuberculosis.

Comments are closed.